Antitumor effect of a new derivative of bleomycin against a cell line of multidrug resistant murine lymphoblastoma.
Yamaki
H
H
Institute of Applied Microbiology, University of Tokyo, Japan.
Nishimura
T
T
Matsunaga
K
K
Suzuki
H
H
Yamaguchi
H
H
Tanaka
N
N
D000818:Animals; D001761:Bleomycin / Q000627:therapeutic use* / Q000031:analogs & derivatives; D004351:Drug Resistance; D007940:Leukemia L5178 / Q000188:drug therapy*; D007942:Leukemia, Experimental / Q000188:drug therapy*; D051379:Mice; D008811:Mice, Inbred DBA; D014407:Tumor Cells, Cultured
C057892:aminopropylmethylpropyl-bleomycin; D001761:Bleomycin